Medical Oncologist
Before you start
Who Is Eligible for — Sorafenib?
Sorafenib is approved for three specific cancer types. If your oncologist has prescribed it, your diagnosis already matches one of them. What decides whether you can start is your liver function, blood pressure, and general fitness — not a separate biomarker test.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026
- Three approved cancers only — Liver, kidney, and radioiodine-refractory thyroid cancer are the only diagnoses where sorafenib is part of standard treatment.
- No biomarker test required — Unlike immunotherapy, eligibility is decided by cancer type, stage, and your blood results — not a PD-L1 or MSI test.
- Liver function matters most — For liver cancer patients, how well your liver still works is the most important check before starting.
- Tablets taken at home — Sorafenib is an oral drug, not an infusion. Your fitness to manage daily tablets and attend monitoring is part of the assessment.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Sorafenib is approved for three cancer types: unresectable liver cancer, advanced kidney cancer, and radioiodine-refractory differentiated thyroid cancer. Unlike immunotherapy, it does not require a biomarker test. Your oncologist decides based on your cancer type, stage, liver function and general fitness.
Why doesn't sorafenib need a biomarker test the way immunotherapy does?
Sorafenib is a kinase inhibitor — it blocks proteins that cancer cells use to build new blood vessels and divide. Those targets are present in the three approved cancer types without needing a molecular fingerprint test first.
Immunotherapy works differently: it only helps when the tumour carries specific markers like PD-L1 or MSI-H, so a test must confirm the match. With sorafenib, your diagnosis does that work.
The checks that matter are your liver function, blood pressure, and general fitness — because those determine whether you can tolerate the drug safely.
Am I likely to be eligible for sorafenib?
- Your cancer is unresectable hepatocellular carcinoma (liver cancer)Surgery or ablation cannot fully remove the tumour, and your liver still functions at an adequate level.
- Your cancer is advanced renal cell carcinoma (kidney cancer)The disease has spread or cannot be surgically removed. Prior treatment history is reviewed as part of the decision.
- Your cancer is differentiated thyroid cancer that no longer responds to radioiodinePapillary or follicular thyroid cancer that has spread locally or to distant sites, after iodine-131 treatment has stopped working.
- Your liver function tests are within an acceptable rangeYour oncologist will review bilirubin, albumin and clotting results before prescribing — whatever your cancer type.
- Your blood pressure is controlled or can be controlled before startingHigh blood pressure is a known side effect of sorafenib. Uncontrolled hypertension is treated first, not a permanent barrier.
- You are fit enough to take daily tablets and attend regular monitoringSorafenib is taken at home by mouth. Your ability to manage this reliably and attend blood test appointments is part of the assessment.
Which cancer types is sorafenib approved for?
| Cancer type | When sorafenib is used | Key check before starting |
|---|---|---|
| Liver cancer (HCC) | Unresectable tumour; liver functioning adequately | Child-Pugh score, performance status |
| Kidney cancer (RCC) | Advanced or metastatic; surgery not possible | Prior treatment history, general fitness |
| Thyroid cancer (DTC) | Radioiodine-refractory, locally advanced or metastatic | Confirmation radioiodine has stopped working |
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
What tests will your oncologist check before prescribing sorafenib?
Your team will review blood tests showing how well your liver processes waste and makes proteins. This matters even if you do not have liver cancer, because sorafenib is broken down by the liver.
Blood pressure is measured because sorafenib can raise it. If yours is already elevated, it will usually be treated and stabilised before you start — not used as a reason to refuse treatment.
Your performance status — how much your illness limits your daily activity — is assessed to confirm you can manage daily tablets and keep up with the monitoring appointments your safety depends on.
Terms you will hear when discussing sorafenib eligibility
- Unresectable
- A tumour that cannot be fully removed by surgery, because of its position, size, or the number of sites affected.
- Child-Pugh score
- A scoring system that measures how well the liver is still functioning — it looks at bilirubin, albumin, clotting, fluid in the abdomen, and mental clarity. Child-Pugh A means the liver is working well enough for sorafenib to be considered.
- ECOG performance status
- A 0–4 scale your oncologist uses to describe how much your illness limits daily activity. Zero means fully active; four means completely dependent on others. Sorafenib is generally considered for patients toward the lower end of this scale.
- Radioiodine-refractory
- Thyroid cancer that has stopped responding to iodine-131 treatment — either because the tumour no longer absorbs the iodine, or because it has continued to spread despite repeated treatments.
- Differentiated thyroid cancer (DTC)
- The most common thyroid cancers — papillary and follicular — which arise from thyroid cells and usually grow slowly. Sorafenib is approved for DTC that has spread and no longer responds to radioiodine.
- Kinase inhibitor
- A drug that blocks specific signalling proteins cancer cells use to grow and form new blood vessels. Sorafenib targets several of these proteins, interrupting the tumour's ability to sustain itself.
Questions families ask most about sorafenib eligibility
Can sorafenib be used for a cancer not on this list?
Sorafenib has been studied in many other cancer types, but CDSCO approval and guidance from NCCN and ESMO covers it only for liver cancer, kidney cancer, and radioiodine-refractory thyroid cancer. Using it outside these indications would be off-label and is not standard practice in India. If your oncologist is considering it for another reason, ask them to explain the specific evidence they are relying on and whether a clinical trial might offer a better-supported option.
My liver function is borderline — does that rule me out completely?
Not automatically. The Child-Pugh classification gives your team a framework, not a single fixed cut-off. Your oncologist will weigh the risk of the drug placing further stress on a liver already working hard against the likely benefit for your cancer. If your results are borderline, the team may want to repeat them after a short interval, or consider a lower starting dose with closer monitoring. Ask specifically what the borderline result means for your situation rather than assuming the answer is no.
I have high blood pressure. Does that stop me from starting?
It is a reason to pause and treat first, not a permanent barrier. NCCN guidance recommends managing hypertension before starting sorafenib and monitoring blood pressure closely throughout treatment, because the drug itself can raise it further. Most patients with well-controlled blood pressure can take sorafenib safely with appropriate follow-up. Your cardiologist or GP may be involved to help bring your readings into an acceptable range before you begin.
I am a woman of childbearing age. Is sorafenib safe to take?
Sorafenib is not safe during pregnancy. It can cause serious harm to a developing baby, and effective contraception is required throughout treatment and for a period after the last dose — ask your oncologist how long that period is for you. Breastfeeding is also not advised while taking sorafenib. If you are pregnant or planning a pregnancy, tell your oncologist before treatment begins so that your team can discuss the options available to you.
I had prior chemotherapy or targeted therapy. Does that affect eligibility?
Prior treatment does not automatically rule out sorafenib. For kidney cancer, it has been used after other treatments have been tried. For liver cancer and thyroid cancer, what matters more is your current liver function and general fitness than your treatment history. Your oncologist will review everything you have had before and explain how it affects the decision and, if relevant, where sorafenib fits in the sequence of options.
Explore 100 more Gastrointestinal & Liver Targeted Medicines topics
Drug Deep Dive: Sorafenib (Nexavar)
- Blood Pressure, Rash and Hair Thinning on Sorafenib
- Diarrhoea on Sorafenib: Controlling It Without Stopping Treatment
- Diet and Nutrition While on Sorafenib
- Drug, Food and Supplement Interactions With Sorafenib
- Fertility, Pregnancy and Contraception on Sorafenib
- Hand-Foot Skin Reaction on Sorafenib: Prevention From Day One
- How Does Sorafenib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Sorafenib Take to Work?
- How Long Will You Stay on Sorafenib?
- Sorafenib (Nexavar, Soranib): The Complete Patient Guide
- Sorafenib Myths: Dose Reduction, 'Last Resort' and Generic Quality
- Sorafenib Price in India: Brand, Generic and Monthly Cost
- Sorafenib Side Effects: The Complete List and Timeline
- Sorafenib Success Rate and Survival: An Honest Look at the Numbers
- Sorafenib With Cirrhosis: Why Child-Pugh Status Decides Eligibility
- Sorafenib With TACE and Other Liver-Directed Treatments
- Sorafenib in Elderly Patients and Those With Other Illnesses
- Sorafenib in Liver, Kidney and Thyroid Cancer: Three Different Uses
- Sorafenib vs Lenvatinib for Liver Cancer: Cost, Tolerability and Evidence
- Taking Sorafenib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Sorafenib
- When Sorafenib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Sorafenib? Liver, Kidney and Radioiodine-Refractory Thyroid Cancer
- Will Insurance or a Government Scheme Pay for Sorafenib?
- Work, Travel and Daily Life on Sorafenib
Drug Deep Dive: Bevacizumab (Avastin)
- Avastin vs Biosimilar Bevacizumab in India: Cost and Safety
- Bevacizumab (Avastin and biosimilars): The Complete Patient Guide
- Bevacizumab Infusion Day: Premedication, Duration and What to Expect
- Bevacizumab Myths: 'It Dissolves Tumours' and Other Misconceptions
- Bevacizumab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Bevacizumab Side Effects: The Complete List and Timeline
- Bevacizumab Success Rate and Survival: An Honest Look at the Numbers
- Bevacizumab With Chemotherapy: Which Combinations and Why
- Bevacizumab in Elderly Patients and Those With Other Illnesses
- Bevacizumab in Eye Disease vs Cancer: Same Drug, Very Different Dose
- Bleeding, Bowel Perforation and Wound Healing Risks on Bevacizumab
- Diet and Nutrition While on Bevacizumab
- Drug, Food and Supplement Interactions With Bevacizumab
- Fertility, Pregnancy and Contraception on Bevacizumab
- High Blood Pressure on Bevacizumab: Monitoring and Treatment
- How Does Bevacizumab Work? The Anti-VEGF Angiogenesis Inhibitor Explained
- How Long Does Bevacizumab Take to Work?
- How Long Will You Stay on Bevacizumab?
- Protein in Your Urine on Bevacizumab: What the Report Means
- Surgery While on Bevacizumab: The 28-Day Rule
- Tests and Monitoring While You Are on Bevacizumab
- When Bevacizumab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Bevacizumab? Colorectal, Lung, Ovarian, Cervical and Brain Cancer
- Will Insurance or a Government Scheme Pay for Bevacizumab?
- Work, Travel and Daily Life on Bevacizumab
Drug Deep Dive: Cetuximab (Erbitux)
- Cetuximab (Erbitux): The Complete Patient Guide
- Cetuximab Infusion Day: Premedication, Duration and What to Expect
- Cetuximab Infusion Reactions: Why the First Dose Is Given Slowly
- Cetuximab Myths: 'The Worse the Rash, the Better' and Other Half-Truths
- Cetuximab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Cetuximab Side Effects: The Complete List and Timeline
- Cetuximab Success Rate and Survival: An Honest Look at the Numbers
- Cetuximab With FOLFIRI, FOLFOX and Radiation
- Cetuximab in Colorectal vs Head and Neck Cancer: Different Roles
- Cetuximab in Elderly Patients and Those With Other Illnesses
- Cetuximab vs Bevacizumab in Colorectal Cancer: Which and When
- Diet and Nutrition While on Cetuximab
- Drug, Food and Supplement Interactions With Cetuximab
- Fertility, Pregnancy and Contraception on Cetuximab
- How Does Cetuximab Work? The Anti-EGFR Monoclonal Antibody Explained
- How Long Does Cetuximab Take to Work?
- How Long Will You Stay on Cetuximab?
- Low Magnesium on Cetuximab: Cramps, Fatigue and Monthly Testing
- Tests and Monitoring While You Are on Cetuximab
- The Cetuximab Rash: Severity, Treatment and Why It Predicts Response
- When Cetuximab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Cetuximab? RAS Wild-Type Colorectal Cancer and Head and Neck Cancer
- Why Cetuximab Only Works in RAS Wild-Type, Left-Sided Tumours
- Will Insurance or a Government Scheme Pay for Cetuximab?
- Work, Travel and Daily Life on Cetuximab
Drug Deep Dive: Lenvatinib (Lenvima)
- Blood Pressure Spikes on Lenvatinib: The Critical First Two Weeks
- Diarrhoea, Appetite Loss and Rapid Weight Drop on Lenvatinib
- Diet and Nutrition While on Lenvatinib
- Dose Reductions on Lenvatinib: Why Most Patients Need One
- Drug, Food and Supplement Interactions With Lenvatinib
- Fertility, Pregnancy and Contraception on Lenvatinib
- Hand-Foot Skin Reaction on Lenvatinib: Prevention and Relief
- How Does Lenvatinib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Lenvatinib Take to Work?
- How Long Will You Stay on Lenvatinib?
- Lenvatinib (Lenvima, Lenvanix): The Complete Patient Guide
- Lenvatinib Myths: Side Effects, Dose Cuts and 'Giving Up'
- Lenvatinib Price in India: Brand, Generic and Monthly Cost
- Lenvatinib Side Effects: The Complete List and Timeline
- Lenvatinib Success Rate and Survival: An Honest Look at the Numbers
- Lenvatinib With Immunotherapy: The Combination Explained
- Lenvatinib for Radioactive-Iodine-Refractory Thyroid Cancer
- Lenvatinib in Elderly Patients and Those With Other Illnesses
- Lenvatinib vs Sorafenib for Liver Cancer: Which Comes First?
- Taking Lenvatinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Lenvatinib
- When Lenvatinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Lenvatinib? Liver, Thyroid, Kidney and Endometrial Cancer
- Will Insurance or a Government Scheme Pay for Lenvatinib?
- Work, Travel and Daily Life on Lenvatinib
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Who can take sorafenib?
Sorafenib is approved for people with unresectable liver cancer, advanced kidney cancer, or differentiated thyroid cancer that has stopped responding to radioiodine treatment. Eligibility also depends on your liver function, blood pressure, and general fitness. Your oncologist reviews blood test results and your performance status before confirming it is appropriate for you — it is not prescribed on diagnosis alone.
Does sorafenib require a biomarker test like PD-L1 or MSI?
No. Sorafenib works by blocking specific growth proteins present in the approved cancer types, without needing a separate molecular test to confirm a match. This sets it apart from checkpoint immunotherapy drugs, which require PD-L1, MSI or TMB testing to establish eligibility. Your diagnosis and your blood results are what your oncologist uses to decide whether sorafenib is appropriate for you.
What is the difference between sorafenib eligibility and chemotherapy eligibility?
Both depend on your fitness and blood results, but they differ in which cancers they treat and how they work. Sorafenib targets specific proteins involved in tumour growth and blood vessel formation; it is approved for liver, kidney, and thyroid cancer rather than the broader range of cancers treated with conventional chemotherapy. Your oncologist will explain which approach fits your specific diagnosis and why.
Can I take sorafenib if I have cirrhosis alongside liver cancer?
It depends on how far the cirrhosis has progressed. The Child-Pugh score measures how well the liver is functioning despite the cirrhosis. Guidance from NCCN and ESMO supports sorafenib for patients whose liver function is Child-Pugh A, meaning it is still working at an adequate level. If your score is higher, your oncologist will discuss the specific risks with you and may explore whether another approach is more appropriate.
Is sorafenib given as an injection or as tablets?
Sorafenib is taken as tablets by mouth, usually at home. This is one of the ways it differs from chemotherapy, which is typically given by infusion in a clinic. You will need to attend regular blood tests and monitoring appointments throughout treatment, but the drug itself is taken at home between those visits.
What should I ask at my eligibility appointment?
Ask four things: which of the three approved cancer types applies to your specific diagnosis, what your liver function tests showed and what the results mean, whether your blood pressure needs treatment before you start, and how long sorafenib treatment is expected to continue. Writing the answers down helps — these appointments are hard to remember fully. It is also reasonable to ask whether any other treatment is an option for your situation, and what sorafenib is intended to achieve.